Cancer Discovery · 2020 · 31 citations · 10 references
MedicineBiomedical SciencesOncologyCancer ControlClinical Research RegulationTranslational OncologyCancer PolicyCancer SurveillanceClinical TrialsClinical Trials In OncologyPandemic ResponseTranslational Cancer ResearchOperational DisruptionPandemic Response PolicyRegulatory Reporting TimelinesRegulatory Timelines
The COVID-19 pandemic has caused widespread disruption of cancer clinical trials due to the restrictions on nonessential services and the reallocation of resources, and at the same time the urgent global effort toward discovering therapies that treat or prevent COVID-19 infection has led to shortening of traditional regulatory timelines. This experience should stimulate similar urgency in the way future cancer research is conducted.
10
Factors associated with COVID-19-related death using OpenSAFELY
Elizabeth Williamson, Alex J Walker, Krishnan Bhaskaran et al. · Nature · 2020 · 6.7K citations · Full text
Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +6
Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Amit Sud, Michael E. Jones, John Broggio et al. · Annals of Oncology · 2020 · 547 citations · Full text
Keep up with the latest coronavirus research
Qingyu Chen, Alexis Allot, Zhiyong Lu · Nature · 2020 · 324 citations · Full text